Improvement of insulin sensitivity in insulin resistant subjects during prolonged treatment with the anti-TNF-α antibody infliximab

Authors


  • Division of Rheumatology (B. Yazdani-Biuki, H. P. Brezinschek, J. Hermann, T. Mueller, W. Graninger), Diabetes and Metabolism Clinic (H. Stelzl, T. C. Wascher), and Division of Oncology ( P. Krippl), Department of Internal Medicine, Medical University Graz, Austria.

Babak Yazdani-Biuki Klinische Abteilung für Rheumatologie Medizinische Universitätsklinik Graz Auenbruggerplatz 15 A-8036 Graz, Austria. Tel.: +43 (316) 385 81835; fax: +43 (316) 385 6853; e-mail: babak.yazdanibiuki@unigraz.at

No abstract is available for this article.

Ancillary